Literature DB >> 61285

Interactions of vesicular stomatitis virus with murine cell surface antigens.

T T Hecht, D F Summers.   

Abstract

The process of maturation of vesicular stomatitis virus (VSV) results in the loss of 70% of the H-2k antigenic activity from L-cell plasma membranes. This phenomenon is also demonstrated during VSV infection of cells of the H-2d haplotype. Using the method of inhibition of immune cytolysis, VSV-infected L5178Y tissue culture cells and VSV-infected METH A fibrosarcoma cells grown in vivo show a loss of H-2d activity of 73 and 76%, respectively. Using monospecific antisera, it is seen that VSV infection results in a significant loss of antigenic activity of the gene products of both the H-2D and H-2K regions in cells of the H-2d and H-2k haplotypes. In hybrid cells expressing H-2k as well as H-2b, VSV infection results in the decrease of both H-2 antigenic activities to the same extent. VSV purified from L cells shows considerable H-2k activity, but the reaction of this virus with anti-H-2k serum does not prevent a normal subsequent infection with this virus. VSV may associate with H-2 antigen in the culture medium, but the results of mixing VSV with uninfected H-2-containing homogenates suggest that this association occurs only when the host cell and the cell homogenate share the same H-2 haplotype. Velocity sedimentation of VSV, which would remove contaminating cellular membrane fragments, does not separate H-2 activity from VSV. H-2 activity is also stably associated with VSV throughout sequential sucrose gradient centrifugation steps. It is possible that H-2 antigen is a structural component of VSV grown in murine cells.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 61285      PMCID: PMC354924     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  SELECTION OF HYBRIDS FROM MATINGS OF FIBROBLASTS IN VITRO AND THEIR PRESUMED RECOMBINANTS.

Authors:  J W LITTLEFIELD
Journal:  Science       Date:  1964-08-14       Impact factor: 47.728

2.  THE ORIGIN OF THE PROTEIN OF SINDBIS VIRUS.

Authors:  E R PFEFFERKORN; R L CLIFFORD
Journal:  Virology       Date:  1964-06       Impact factor: 3.616

3.  Studies of the culture of leukemic cells in vitro.

Authors:  G A FISCHER
Journal:  Ann N Y Acad Sci       Date:  1958-12-05       Impact factor: 5.691

4.  The development and structure of vesicular stomatitis virus.

Authors:  A F HOWATSON; G F WHITMORE
Journal:  Virology       Date:  1962-04       Impact factor: 3.616

5.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

6.  The distribution of alloantigenic specificities of native H-2 products.

Authors:  S E Cullen; B D Schwartz; S G Nathenson
Journal:  J Immunol       Date:  1972-03       Impact factor: 5.422

7.  Regeneration of transplantation antigens on mouse cells.

Authors:  B D Schwartz; S G Nathenson
Journal:  Transplant Proc       Date:  1971-03       Impact factor: 1.066

8.  Evidence that H-2 private specificities can be arranged in two mutually exclusive systems possibly homologous with two subsystems of HL-A.

Authors:  G D Snell; M Cherry; P Démant
Journal:  Transplant Proc       Date:  1971-03       Impact factor: 1.066

9.  Distribution of H-2 alloantigenic specificities on radiolabeled papain-solubilized antigen fragments.

Authors:  S E Cullen; S G Nathenson
Journal:  J Immunol       Date:  1971-08       Impact factor: 5.422

10.  Proteins of vesicular stomatitis virus and of phenotypically mixed vesicular stomatitis virus-simian virus 5 virions.

Authors:  J J McSharry; R W Compans; P W Choppin
Journal:  J Virol       Date:  1971-11       Impact factor: 5.103

View more
  18 in total

1.  Stereo images of vesicular stomatitis virus assembly.

Authors:  W F Odenwald; H Arnheiter; M Dubois-Dalcq; R A Lazzarini
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

2.  Assembly of vesicular stomatitis virus: distribution of the glycoprotein on the surface of infected cells.

Authors:  B L Jacobs; E E Penhoet
Journal:  J Virol       Date:  1982-12       Impact factor: 5.103

3.  H-2Kk and vesicular stomatitis virus G proteins are not extensively associated in reconstituted membranes recognized by T cells.

Authors:  G S Cartwright; L M Smith; E W Heinzelmann; M J Ruebush; J W Parce; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

4.  Heterogeneity of vesicular stomatitis virus particles: implications for virion assembly.

Authors:  H F Lodish; M Porter
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

5.  Molecular association between transplantation antigens and cell surface antigen in adenovirus-transformed cell line.

Authors:  S Kvist; L Ostberg; H Persson; L Philipson; P A Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

6.  Does the major histocompatibility complex serve as a specific receptor for Semliki Forest virus?

Authors:  M B Oldstone; A Tishon; F J Dutko; S I Kennedy; J J Holland; P W Lampert
Journal:  J Virol       Date:  1980-04       Impact factor: 5.103

7.  Virus-induced decrease of insulin receptors in cultured human cells.

Authors:  F Shimizu; J J Hooks; C R Kahn; A L Notkins
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

8.  Detection of the cellular membrane proteins on human T cell leukemia virus type I.

Authors:  H Akari; Y Goto; T Shinjo
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

9.  Effects of antiviral agents on murine cytomegalovirus-induced macrophage dysfunction.

Authors:  J D Shanley; E L Pesanti
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

10.  "Natural" antibodies to chicken MHC antigens are present in mice, rats, humans, alligators and allogeneic chickens.

Authors:  B M Longenecker; T R Mosmann
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.